Marianne P. Allen

Array ( [id] => 3563687 [patent_doc_number] => 05525708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Covalent dimer of kit ligand' [patent_app_type] => 1 [patent_app_number] => 8/220379 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 9889 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525708.pdf [firstpage_image] =>[orig_patent_app_number] => 220379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3487580 [patent_doc_number] => 05474981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Use of the cytokine IP-10 as an anti-tumor agent' [patent_app_type] => 1 [patent_app_number] => 8/217016 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5647 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474981.pdf [firstpage_image] =>[orig_patent_app_number] => 217016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687603 [patent_doc_number] => 05603934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy' [patent_app_type] => 1 [patent_app_number] => 8/210732 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 4268 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/603/05603934.pdf [firstpage_image] =>[orig_patent_app_number] => 210732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3487084 [patent_doc_number] => 05439679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'Peptide plasminogen activators' [patent_app_type] => 1 [patent_app_number] => 8/208202 [patent_app_country] => US [patent_app_date] => 1994-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5549 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/439/05439679.pdf [firstpage_image] =>[orig_patent_app_number] => 208202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866154 [patent_doc_number] => 05837498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Corpuscles of stannius protein, stanniocalcin' [patent_app_type] => 1 [patent_app_number] => 8/208005 [patent_app_country] => US [patent_app_date] => 1994-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8064 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837498.pdf [firstpage_image] =>[orig_patent_app_number] => 208005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691135 [patent_doc_number] => 05650147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Methods of stimulating granulocyte-macrophage progenitor cells' [patent_app_type] => 1 [patent_app_number] => 8/207887 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8122 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650147.pdf [firstpage_image] =>[orig_patent_app_number] => 207887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548824 [patent_doc_number] => 05545719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Nerve growth peptides' [patent_app_type] => 1 [patent_app_number] => 8/201046 [patent_app_country] => US [patent_app_date] => 1994-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 11044 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545719.pdf [firstpage_image] =>[orig_patent_app_number] => 201046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420120 [patent_doc_number] => 06506727 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Nerve regeneration' [patent_app_type] => B1 [patent_app_number] => 08/198542 [patent_app_country] => US [patent_app_date] => 1994-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5577 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506727.pdf [firstpage_image] =>[orig_patent_app_number] => 08198542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342312 [patent_doc_number] => 06586394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Tissue-derived tumor growth inhibitor' [patent_app_type] => B1 [patent_app_number] => 08/188197 [patent_app_country] => US [patent_app_date] => 1994-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 39 [patent_no_of_words] => 35599 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586394.pdf [firstpage_image] =>[orig_patent_app_number] => 08188197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586764 [patent_doc_number] => 05516654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Production of recombinant bone-inducing proteins' [patent_app_type] => 1 [patent_app_number] => 8/187921 [patent_app_country] => US [patent_app_date] => 1994-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1262 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516654.pdf [firstpage_image] =>[orig_patent_app_number] => 187921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3426062 [patent_doc_number] => 05459250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Truncated mammalian growth factor DNA sequence' [patent_app_type] => 1 [patent_app_number] => 8/187780 [patent_app_country] => US [patent_app_date] => 1994-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6309 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459250.pdf [firstpage_image] =>[orig_patent_app_number] => 187780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3581236 [patent_doc_number] => 05498599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Methods for stimulating platelet production' [patent_app_type] => 1 [patent_app_number] => 8/184327 [patent_app_country] => US [patent_app_date] => 1994-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8111 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498599.pdf [firstpage_image] =>[orig_patent_app_number] => 184327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4131674 [patent_doc_number] => 06034060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Peptide having an ability to promote the activation of protein C by thrombin' [patent_app_type] => 1 [patent_app_number] => 8/181458 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 29 [patent_no_of_words] => 22840 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034060.pdf [firstpage_image] =>[orig_patent_app_number] => 181458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3110927 [patent_doc_number] => 05408041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-18 [patent_title] => 'Process of purifying antler-derived bone growth factors' [patent_app_type] => 1 [patent_app_number] => 8/180572 [patent_app_country] => US [patent_app_date] => 1994-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 16985 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/408/05408041.pdf [firstpage_image] =>[orig_patent_app_number] => 180572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585487 [patent_doc_number] => 05552300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'T cell antigen receptor V region proteins and methods of preparation thereof' [patent_app_type] => 1 [patent_app_number] => 8/181492 [patent_app_country] => US [patent_app_date] => 1994-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20829 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552300.pdf [firstpage_image] =>[orig_patent_app_number] => 181492 [rel_patent_id] =>[rel_patent_doc_number] =>)